Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 61
Filter
1.
Diabet Med ; 31(9): 1064-8, 2014 09.
Article in English | MEDLINE | ID: mdl-24646311

ABSTRACT

AIMS: To determine if the presence of diabetes autoantibodies predicts the development of diabetes among participants in the Diabetes Prevention Program. METHODS: A total of 3050 participants were randomized into three treatment groups: intensive lifestyle intervention, metformin and placebo. Glutamic acid decarboxylase (GAD) 65 autoantibodies and insulinoma-associated-2 autoantibodies were measured at baseline and participants were followed for 3.2 years for the development of diabetes. RESULTS: The overall prevalence of GAD autoantibodies was 4.0%, and it varied across racial/ethnic groups from 2.4% among Asian-Pacific Islanders to 7.0% among non-Hispanic black people. There were no significant differences in BMI or metabolic variables (glucose, insulin, HbA(1c), estimated insulin resistance, corrected insulin response) stratified by baseline GAD antibody status. GAD autoantibody positivity did not predict diabetes overall (adjusted hazard ratio 0.98; 95% CI 0.56-1.73) or in any of the three treatment groups. Insulinoma-associated-2 autoantibodies were positive in only one participant (0.033%). CONCLUSIONS: These data suggest that 'diabetes autoimmunity', as reflected by GAD antibodies and insulinoma-associated-2 autoantibodies, in middle-aged individuals at risk for diabetes is not a clinically relevant risk factor for progression to diabetes.


Subject(s)
Autoantibodies/blood , Diabetes Mellitus/immunology , Glutamate Decarboxylase/immunology , Hypoglycemic Agents/therapeutic use , Insulin Resistance , Islets of Langerhans/metabolism , Metformin/therapeutic use , Receptor-Like Protein Tyrosine Phosphatases, Class 8/immunology , Risk Reduction Behavior , Autoantibodies/immunology , Autoimmunity , Blood Glucose/metabolism , Diabetes Mellitus/prevention & control , Disease Progression , Female , Follow-Up Studies , Humans , Insulin/immunology , Insulin/metabolism , Insulin Resistance/immunology , Insulin Secretion , Male , Middle Aged , Predictive Value of Tests , Prevalence , Treatment Outcome
2.
Diabetes Obes Metab ; 16(6): 510-8, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24298995

ABSTRACT

AIMS: To compare efficacy and safety of two, once-daily basal insulin formulations [insulin lispro protamine suspension (ILPS) vs. insulin glargine (glargine)] added to oral antihyperglycaemic medications (OAMs) and exenatide BID in suboptimally controlled type 2 diabetes (T2D) patients. METHODS: This 24-week, open-label, multicentre trial randomized patients to bedtime ILPS (n = 171) or glargine (n = 168). Non-inferiority of ILPS versus glargine was assessed by comparing the upper limit of 95% confidence intervals (CIs) for change in haemoglobin A1c (HbA1c) from baseline to week 24 (adjusted for baseline HbA1c) with non-inferiority margin 0.4%. RESULTS: Non-inferiority of ILPS versus glargine was demonstrated: least-squares mean between-treatment difference (ILPS minus glargine) (95% CI) was 0.22% (0.06, 0.38). Mean HbA1c reduction was less for ILPS- versus glargine-treated patients (-1.16 ± 0.84 vs. -1.40 ± 0.97%, p = 0.008). Endpoint HbA1c < 7.0% was achieved by 53.7% (ILPS) and 61.7% (glargine) (p = NS). Overall hypoglycaemia rates (p = NS) and severe hypoglycaemia incidence (p = NS) were similar. Nocturnal hypoglycaemia rate was higher in patients treated with ILPS versus glargine (p = 0.004). Weight gain was similar between groups (ILPS: 0.27 ± 3.38 kg; glargine: 0.66 ± 3.93 kg, p = NS). Endpoint total insulin doses were lower in patients treated with ILPS versus glargine (0.30 ± 0.17 vs. 0.37 ± 0.17 IU/kg/day, p < 0.001). CONCLUSIONS: ILPS was non-inferior to glargine for HbA1c change over 24 weeks, but was associated with less HbA1c reduction and more nocturnal hypoglycaemia. Treat-to-target basal insulin therapy improves glycaemic control and is associated with minimal weight gain when added to OAMs and exenatide BID for suboptimally controlled T2D.


Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Hyperglycemia/drug therapy , Hypoglycemic Agents/administration & dosage , Insulin Lispro/administration & dosage , Insulin, Long-Acting/administration & dosage , Administration, Oral , Adolescent , Adult , Aged , Diabetes Mellitus, Type 2/metabolism , Female , Glycated Hemoglobin/metabolism , Humans , Hyperglycemia/metabolism , Hypoglycemia/chemically induced , Hypoglycemic Agents/adverse effects , Insulin Glargine , Insulin Lispro/adverse effects , Insulin, Long-Acting/adverse effects , Male , Middle Aged , Protamines/administration & dosage , Protamines/adverse effects , Treatment Outcome , Weight Gain , Young Adult
3.
Braz. j. microbiol ; 44(4): 1207-1214, Oct.-Dec. 2013. ilus, tab
Article in English | LILACS | ID: lil-705249

ABSTRACT

Fungi have been recently recognized as organisms able to grow in presence of high salt concentration with halophilic and halotolerance properties and their ligninolytic enzyme complex have an unspecific action enabling their use to degradation of a number of xenobiotic compounds. In this work, both the effect of salt and polyols on growth of the basidiomycetes strains, on their ability to produce ligninolytic enzyme and diuron degradation were evaluated. Results showed that the presence of NaCl in the culture medium affected fungal specimens in different ways. Seven out of ten tested strains had growth inhibited by salt while Dacryopinax elegans SXS323, Polyporus sp MCA128 and Datronia stereoides MCA167 fungi exhibited higher biomass production in medium containing 0.5 and 0.6 mol.L-1 of NaCl, suggesting to be halotolerant. Polyols such as glycerol and mannitol added into the culture media improved the biomass and ligninases production by D. elegans but the fungus did not reveal consumption of these polyols from media. This fungus degraded diuron in medium control, in presence of NaCl as well as polyols, produced MnP, LiP and laccase.


Subject(s)
Basidiomycota/enzymology , Basidiomycota/metabolism , Herbicides/metabolism , Oxygenases/metabolism , Sodium Chloride/metabolism , Biomass , Biotransformation , Basidiomycota/drug effects , Basidiomycota/growth & development , Culture Media/chemistry , Diuron/metabolism , Growth Inhibitors/metabolism , Growth Inhibitors/toxicity , Polymers/metabolism , Polymers/toxicity , Sodium Chloride/toxicity
4.
J Clin Endocrinol Metab ; 98(10): 3989-98, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23979954

ABSTRACT

CONTEXT: Although intensive lifestyle change (ILS) and metformin reduce diabetes incidence in subjects with impaired glucose tolerance (IGT), their effects on lipoprotein subfractions have not been studied. OBJECTIVE: The objective of the study was to characterize the effects of ILS and metformin vs placebo interventions on lipoprotein subfractions in the Diabetes Prevention Program. DESIGN: This was a randomized clinical trial, testing the effects of ILS, metformin, and placebo on diabetes development in subjects with IGT. PARTICIPANTS: Selected individuals with IGT randomized in the Diabetes Prevention Program participated in the study. INTERVENTIONS: Interventions included randomization to metformin 850 mg or placebo twice daily or ILS aimed at a 7% weight loss using a low-fat diet with increased physical activity. MAIN OUTCOME MEASURES: Lipoprotein subfraction size, density, and concentration measured by magnetic resonance and density gradient ultracentrifugation at baseline and 1 year were measured. RESULTS: ILS decreased large and buoyant very low-density lipoprotein, small and dense low-density lipoprotein (LDL), and small high-density lipoprotein (HDL) and raised large HDL. Metformin modestly reduced small and dense LDL and raised small and large HDL. Change in insulin resistance largely accounted for the intervention-associated decreases in large very low-density lipoprotein, whereas changes in body mass index (BMI) and adiponectin were strongly associated with changes in LDL. Baseline and a change in adiponectin were related to change in large HDL, and BMI change associated with small HDL change. The effect of metformin to increase small HDL was independent of adiponectin, BMI, and insulin resistance. CONCLUSION: ILS and metformin treatment have favorable effects on lipoprotein subfractions that are primarily mediated by intervention-related changes in insulin resistance, BMI, and adiponectin. Interventions that slow the development of diabetes may also retard the progression of atherosclerosis.


Subject(s)
Diabetes Mellitus, Type 2/prevention & control , Hypoglycemic Agents/therapeutic use , Life Style , Lipoproteins/blood , Metformin/therapeutic use , Risk Reduction Behavior , Adult , Body Mass Index , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/drug therapy , Diet, Fat-Restricted , Female , Humans , Male , Middle Aged , Treatment Outcome
5.
Braz J Microbiol ; 44(4): 1207-14, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24688513

ABSTRACT

Fungi have been recently recognized as organisms able to grow in presence of high salt concentration with halophilic and halotolerance properties and their ligninolytic enzyme complex have an unspecific action enabling their use to degradation of a number of xenobiotic compounds. In this work, both the effect of salt and polyols on growth of the basidiomycetes strains, on their ability to produce ligninolytic enzyme and diuron degradation were evaluated. Results showed that the presence of NaCl in the culture medium affected fungal specimens in different ways. Seven out of ten tested strains had growth inhibited by salt while Dacryopinax elegans SXS323, Polyporus sp MCA128 and Datronia stereoides MCA167 fungi exhibited higher biomass production in medium containing 0.5 and 0.6 mol.L(-1) of NaCl, suggesting to be halotolerant. Polyols such as glycerol and mannitol added into the culture media improved the biomass and ligninases production by D. elegans but the fungus did not reveal consumption of these polyols from media. This fungus degraded diuron in medium control, in presence of NaCl as well as polyols, produced MnP, LiP and laccase.


Subject(s)
Basidiomycota/enzymology , Basidiomycota/metabolism , Herbicides/metabolism , Oxygenases/metabolism , Sodium Chloride/metabolism , Basidiomycota/drug effects , Basidiomycota/growth & development , Biomass , Biotransformation , Culture Media/chemistry , Diuron/metabolism , Growth Inhibitors/metabolism , Growth Inhibitors/toxicity , Polymers/metabolism , Polymers/toxicity , Sodium Chloride/toxicity
6.
Genet Mol Res ; 9(3): 1877-85, 2010 Sep 21.
Article in English | MEDLINE | ID: mdl-20882483

ABSTRACT

The nucleolar material of Chariesterus armatus was analyzed during spermiogenesis in cell preparations impregnated with silver nitrate. Nucleolar corpuscles were observed in spermatids at the beginning of the process, showing that this organoid is also maintained after meiosis. In addition, nucleoli were seen in the round spermatids connected to the X-chromosome (bearer of the nucleolar organizer in C. armatus), indicating de novo synthesis of nucleolar material. This differs from the reorganization of ribosomal granules, transported from meiotic spermatocytes to round spermatids, where they would support protein synthesis, which is reported for other species. We also observed connections of nucleolar corpuscles to the nuclear membrane regions where the tail and the acrosome will be formed, suggesting close involvement of the nucleolar material in the formation of these structures. In addition to the nucleolar bodies, we detected silver-positive structures, which will require new approaches to clarify their role. One of these structures, observed in the cytoplasm, appears to correspond to the chromatoid body, which has been found in several organisms, but is still poorly understood; another is a complex structure to which the tail appears to be connected. We conclude that C. armatus is an appropriate model for understanding not only the synthesis of rRNA in the spermiogenesis, but also the functional meaning of the close relationship of nucleolar material with other structures during this process.


Subject(s)
Cell Nucleolus/metabolism , Cytogenetics/methods , Heteroptera/cytology , Heteroptera/metabolism , RNA, Ribosomal/biosynthesis , Spermatogenesis/physiology , Acrosome/metabolism , Animals , Male , Spermatids/cytology , Spermatids/metabolism
7.
Diabetes Technol Ther ; 11 Suppl 2: S53-61, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19772450

ABSTRACT

BACKGROUND: Insulin initiation and optimization is a challenge for patients with type 2 diabetes. Our objective was to determine whether safety and efficacy of AIR inhaled insulin (Eli Lilly and Co., Indianapolis, IN) (AIR is a registered trademark of Alkermes, Inc., Cambridge, MA) using a simplified regimen was noninferior to an intensive regimen. METHODS: This was an open-label, randomized study in insulin-naive adults not optimally controlled by oral antihyperglycemic medications. Simplified titration included a 6 U per meal AIR insulin starting dose. Individual doses were adjusted at mealtime in 2-U increments from the previous day's four-point self-monitored blood glucose (SMBG) (total < or =6 U). Starting Air insulin doses for intensive titration were based on fasting blood glucose, gender, height, and weight. Patients conducted four-point SMBG daily for the study duration. Insulin doses were titrated based on the previous 3 days' mean SMBG (total < or =8 U). RESULTS: End point hemoglobin A1C (A1C) was 7.07 +/- 0.09% and 6.87 +/- 0.09% for simplified (n = 178) and intensive (n = 180) algorithms, respectively. Noninferiority between algorithms was not established. The fasting blood glucose (least squares mean +/- standard error) values for the simplified (137.27 +/- 3.42 mg/dL) and intensive (133.13 +/- 3.42 mg/dL) algorithms were comparable. Safety profiles were comparable. The hypoglycemic rate at 4, 8, 12, and 24 weeks was higher in patients receiving intensive titration (all P < .0001). The nocturnal hypoglycemic rate for patients receiving intensive titration was higher than for those receiving simplified titration at 8 (P < 0.015) and 12 weeks (P < 0.001). CONCLUSIONS: Noninferiority between the algorithms, as measured by A1C, was not demonstrated. This finding re-emphasizes the difficulty of identifying optimal, simplified insulin regimens for patients.


Subject(s)
Administration, Inhalation , Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/therapeutic use , Insulin/administration & dosage , Insulin/therapeutic use , Adult , Aged , Body Mass Index , Diabetes Mellitus, Type 2/blood , Drug Therapy, Combination , Female , Forced Expiratory Volume/drug effects , Glycated Hemoglobin/drug effects , Glycated Hemoglobin/metabolism , Humans , Hypoglycemia/epidemiology , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/adverse effects , Insulin/adverse effects , Male , Metformin/therapeutic use , Middle Aged , Thiazolidinediones/therapeutic use , Vital Capacity/drug effects
8.
In Vitro Cell Dev Biol Anim ; 36(5): 293-8, 2000 May.
Article in English | MEDLINE | ID: mdl-10937832

ABSTRACT

Cell-free translation/translocation systems are broadly applied to examine gene expression and characterize the structure-function relationship of gene products. We present the characterization of Xenopus egg extract (XEE) translocation and processing of proteins synthesized in rabbit reticulocyte lysate. The XEE was prepared from eggs laid by adult female frogs that received serial injections of gonadotropins. The eggs were then dejellied in 2% L-cysteine-HCl and the cytoplasm extracted by centrifugation at 10,000 rpm for 15 min. The in vitro translocation and processing of XEE was examined with a cell-free translation system containing reticulocyte lysate, and appropriate messenger ribonucleic acid (RNA) or complementary deoxyribonucleic acid plasmids with RNA polymerase. Cell-free production of the following proteins were used to assess posttranslational modifications: Escherichia coli beta-lactamase for signal sequence cleavage, Saccharomyces cerevisiae alpha-mating factor for translocation and N-linked glycosylation, the soluble protein luciferase for functional activity, and the membrane-bound human insulin receptor for translation efficiency. All translation products were identified by [35S]-methionine labeling, sodium dodecyl sulfate-polyacrylamide gel electrophoresis and fluorography. The results demonstrate that (1) XEE produces near-complete signal sequence and N-glycosylation processing of proteins synthesized in reticulocyte lysate, (2) XEE contains endoplasmic reticulum-equivalent microsomes, which allows for protein translocation and protease protection, (3) the addition of XEE in the translation reaction does not affect synthesis and chemiluminescence activity of luciferase, (4) XEE is efficient in processing the nascent 160-kDa human insulin receptor precursor, a transmembrane protein, and (5) as compared to canine pancreatic microsomes, XEE translocation efficiency is minimally decreased with the addition of dimethylsulfoxide. These results are the first description of the combined use of XEE with reticulocyte lysate and clearly demonstrate a higher efficiency of translocation and processing compared to canine pancreatic microsomes. This method of cell-free translation and processing allows for more extensive in vitro examination of posttranslational modifications of secretory and membrane-bound proteins.


Subject(s)
Protein Biosynthesis , Protein Processing, Post-Translational , Reticulocytes/metabolism , Animals , Biological Transport , Cell Extracts , Dogs , Endoplasmic Reticulum/metabolism , Female , Humans , Mating Factor , Ovum/metabolism , Peptides/genetics , RNA, Messenger/metabolism , Rabbits , Receptor, IGF Type 1/biosynthesis , Receptor, Insulin/biosynthesis , Xenopus , beta-Lactamases/genetics
10.
Int J Antimicrob Agents ; 14(3): 203-7, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10773488

ABSTRACT

Previous studies have demonstrated the relationship between radical intensity and cytotoxic activity in water-soluble compounds. This relationship was investigated in lipophilic compounds. Several N-acylphenothiazines showed higher cytotoxic activity against human leukemic and squamous carcinoma cell lines than phenothiazine, the parent compound. Electron spin resonance (ESR) spectroscopy showed that these active compounds produced much lower amounts of radicals than phenothiazine. Several compounds failed to inhibit the cytopathic effects of human immunodeficiency virus (HIV) infection in MT-4 cells. It suggested that the radical-mediated-mechanisms has not involved in the induction of cytotoxic activity by lipophilic compounds, such as N-acylphenothiazines.


Subject(s)
Anti-HIV Agents/pharmacology , Antipsychotic Agents/pharmacology , Cytopathogenic Effect, Viral/drug effects , Phenothiazines/pharmacology , Anti-HIV Agents/chemical synthesis , Electron Spin Resonance Spectroscopy , Free Radicals , HIV-1/drug effects , HIV-1/physiology , HL-60 Cells , Humans , Phenothiazines/chemical synthesis
11.
FEBS Lett ; 457(1): 13-7, 1999 Aug 20.
Article in English | MEDLINE | ID: mdl-10486554

ABSTRACT

The cell-free examination of the human insulin receptor during biogenesis may provide a greater understanding of the elements that contribute to the acquisition of receptor function. The insulin receptor precursor components were produced in a cell-free system and the insulin binding ability of the [35S]methionine-labeled translation products was determined. The processed proreceptor represented by a 190 kDa band was retained on insulin-linked biotin-streptavidin agarose or an insulin column. The insulin binding 190 kDa band migrated slower than the non-binding 190 kDa band on SDS-PAGE which suggests that covalent modifications account for these differences. The trypsin-digested product of the 190 kDa proreceptor was also retained on insulin-linked biotin-streptavidin agarose, however the alpha-subunit precursor was retained on insulin agarose to a much lesser degree. We conclude that a significant fraction of the processed, in vitro translated insulin proreceptor acquires insulin binding ability.


Subject(s)
Insulin/metabolism , Protein Precursors/metabolism , Receptor, Insulin/metabolism , Recombinant Proteins/metabolism , Animals , Cell-Free System , Cells, Cultured , Chromatography, Affinity , Humans , Lectins/metabolism , Ligands , Membrane Proteins/metabolism , Peptide Hydrolases/metabolism , Protein Binding , Protein Biosynthesis , Protein Precursors/genetics , Protein Processing, Post-Translational , Receptor, Insulin/genetics , Recombinant Proteins/genetics , Reticulocytes/metabolism , Transcription, Genetic , Trypsin/pharmacology , Xenopus/embryology
12.
AIDS ; 13(11): 1359-65, 1999 Jul 30.
Article in English | MEDLINE | ID: mdl-10449289

ABSTRACT

OBJECTIVE: To identify metabolic and body composition changes associated with HIV-1 infection in a cross-sectional study of individuals stratified by immunologic status and body mass. DESIGN: Metabolic abnormalities including glucose intolerance and changes in body morphology have recently been described in HIV-1-infected individuals following therapy with protease inhibitor-containing highly active anti-retroviral therapy. Although this is suggestive of a direct drug effect, the possibility that HIV infection may induce a tendency towards such underlying derangements should be considered. HIV-infected patients are heterogeneous with respect to immunologic status and body mass. In examining the underlying effect of HIV-1 on metabolic and body composition parameters, stratification by various immunologic and body mass categories may give divergent results that would not be detected otherwise. METHODS: Thirty male participants were categorized into four cohorts: non-wasting HIV-seronegative controls, non-wasting HIV-infected patients with relatively intact immune function (CD4 cell count > 500 x 10(6)/l); non-wasting individuals with AIDS (CD4 cell count < 200 x 10(6)/l); and individuals with AIDS wasting. RESULTS: Increased fasting plasma insulin and waist-to-hip ratios were found specifically in non-wasting individuals with AIDS compared with HIV-negative controls. CONCLUSIONS: Our study emphasises the importance of both body mass and immune function in studying metabolic and body composition abnormalities associated with HIV-1 infection. The association of increased waist-to-hip ratios and hyperinsulinemia suggestive of insulin resistance in non-wasting individuals with AIDS suggest that the tendency towards these metabolic abnormalities may be related to the HIV infectious process or to factors associated with immunologic dysfunction.


Subject(s)
Body Constitution , HIV Infections/physiopathology , Hyperinsulinism , Insulin/blood , Anthropometry , Blood Glucose/metabolism , CD4 Lymphocyte Count , Cohort Studies , Cross-Sectional Studies , Fasting , HIV Infections/blood , HIV Infections/immunology , HIV Wasting Syndrome/blood , HIV Wasting Syndrome/immunology , HIV-1/physiology , Humans , Male , RNA, Viral/blood
13.
Anticancer Res ; 19(2A): 1125-9, 1999.
Article in English | MEDLINE | ID: mdl-10368663

ABSTRACT

The relationship between radical intensity and biological activity of cacao husk extracts was investigated. Electron spin resonance (ESR) spectroscopy demonstrated that the radical intensity of hexane, acetone, methanol and 70% methanol extracts increased with water-solubility. Several fractions of these husk extracts, separated by different column chromatographies, significantly inhibited the cytopathic effect of human immunodeficiency virus (HIV) infection in parallel with their radical intensity. However, their cytotoxic activity against human leukemic and carcinoma cell lines is not always correlated with their radical intensity. Water-soluble and lipophilic compounds might induce cytotoxic activity by different mechanisms.


Subject(s)
Cacao , Anti-HIV Agents/pharmacology , Free Radicals , HL-60 Cells , Humans , Plant Extracts/chemistry , Plant Extracts/pharmacology , Solubility
14.
Anticancer Res ; 19(1A): 357-64, 1999.
Article in English | MEDLINE | ID: mdl-10226567

ABSTRACT

The radical modulation activity of lignins prepared from the cone of Pinus elliottii var. Elliottii was investigated, using ESR spectroscopy. These lignins produced radical(s) under alkaline conditions, and the radical intensity was increased with increasing pH. Lower concentrations of lignins slightly reduced the radical intensity of sodium ascorbate, whereas higher concentrations of lignins enhanced both the radical intensity and cytotoxic activity of sodium ascorbate. Lignins effectively scavenged superoxide anion, produced by hypoxanthine-xanthine oxidase reaction. Elliottii lignins significantly inhibited the human immunodeficiency virus (HIV)-induced cytopathic effect, in similar fashions to other natural, commercial and synthetic lignins. Pretreatment of mice with lignins significantly protected them from the lethal infection with E. coli. Crude alkaline extracts of Elliottii pine cone displayed similar magnitude of activity with lignins. These data further supports the medicinal efficacy of plant extracts.


Subject(s)
Lignin/pharmacology , Plants, Medicinal , Animals , Anti-HIV Agents/pharmacology , Ascorbic Acid/pharmacology , Free Radicals , Humans , Male , Mice , Plant Extracts/pharmacology , Superoxides/metabolism
15.
J Immunol ; 162(9): 5417-22, 1999 May 01.
Article in English | MEDLINE | ID: mdl-10228019

ABSTRACT

Recent studies have demonstrated that human herpesvirus 6 (HHV-6) and HHV-7 interact with HIV-1 and alter the expression of various surface molecules and functions of T lymphocytes. The present study was undertaken to clarify whether coreceptors for HIV-1, CXCR4 and CCR5, are necessary for HHV-6 and HHV-7 infection. Although CXCR4 and CCR5 appeared not to be the coreceptors for these viruses, marked down-regulation of CXCR4, but not CCR5, was detected in HHV-6 variant A (HHV-6A)-, HHV-6 variant B (HHV-6B)-, and HHV-7-infected cells. Down-regulation of CXCR4 resulted in impairment of chemotaxis and a decreased level of elevation of the intracellular Ca2+ concentration in response to stromal cell-derived factor-1. Northern blot analysis of mRNAs extracted from HHV-6A-, HHV-6B-, and HHV-7-infected CD4+ T lymphocytes demonstrated a markedly decreased level of CXCR4 gene transcription, but the posttranscriptional stability of CXCR4 mRNA was not significantly altered. These data demonstrate that unlike HIV-1, HHV-6 and HHV-7 infections do not require expression of CXCR4 or CCR5, whereas marked down-regulation of CXCR4 is induced by these viruses, suggesting that HHV-6 and HHV-7 infections may render CD4+ T lymphocytes resistant to T lymphocyte-tropic HIV-1 infection.


Subject(s)
Down-Regulation/immunology , Herpesvirus 6, Human/physiology , Herpesvirus 7, Human/physiology , Receptors, CXCR4/antagonists & inhibitors , Antibodies, Monoclonal/pharmacology , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , CD4-Positive T-Lymphocytes/virology , Cell Movement/immunology , Cells, Cultured , Chemokine CXCL12 , Chemokines, CXC/physiology , Humans , RNA, Messenger/antagonists & inhibitors , RNA, Messenger/biosynthesis , Receptors, CXCR4/genetics , Receptors, CXCR4/immunology , Virus Replication/immunology
16.
J Biol Chem ; 274(19): 13541-6, 1999 May 07.
Article in English | MEDLINE | ID: mdl-10224123

ABSTRACT

In this study, we show that N-acetylcysteine (NAC), a precursor of glutathione and an intracellular free radical scavenger, almost completely prevented hepatocyte growth factor (HGF)-suppressed growth of Sarcoma 180 and Meth A cells, and HGF-induced apoptosis, assessed by DNA fragmentation, and increase in caspase-3 activity, in Sarcoma 180 cells. The reduced form of glutathione also prevented HGF-suppressed growth of the cells as effective as NAC. Ascorbic acid partially prevented the effect of HGF, but other antioxidants such as superoxide dismutase, catalase, and vitamin E, and the free radical spin traps N-t-butyl-alpha-phenylnitrone and 3,3,5, 5-tetramethyl-1-pyrroline-1-oxide did not have protective effects. HGF caused morphological changes of the cells, many cells showing condensation and rounding, and enhanced the generation of intracellular reactive oxygen species (ROS) as judged by flow cytometric analysis using 2',7'-dichlorofluorescein diacetate. NAC completely prevented both HGF-induced morphological changes and the enhancement of ROS generation in the cells. However, NAC did not prevent the HGF-induced scattering of Madin-Darby canine kidney cells. To our knowledge, this is the first report that HGF stimulates the production of ROS, and our results suggest the involvement of oxidative stress in the mechanism by which HGF induces growth suppression of tumor cells.


Subject(s)
Cell Division/physiology , Hepatocyte Growth Factor/physiology , Sarcoma, Experimental/pathology , Acetylcysteine/pharmacology , Animals , Antioxidants/pharmacology , Apoptosis , Cell Line , Dogs , Oxidative Stress , Reactive Oxygen Species , Tumor Cells, Cultured
17.
AIDS Res Hum Retroviruses ; 15(5): 419-27, 1999 Mar 20.
Article in English | MEDLINE | ID: mdl-10195751

ABSTRACT

T22 ([Tyr5,12, Lys7]-polyphemusin II) is a strong anti-HIV compound. Six analogs of T22 and two natural forms were synthesized. Of them, all downsized peptides (14 residues; TW70, T131, T134, and T140) showed a higher selectivity index than did other, 17- or 18-residue peptides. In particular, T134 and T140 showed both lower cytotoxicity and higher antiviral activity than did T22 against HIV infection of MT-4 cells, an HTLV-I-bearing T cell line. To clarify the inhibitory mode of T22 and its analogs, we used a single-round replication assay (luciferase assay), in which different envelope-bearing pseudotypes were used to infect CXCR4- or CCR5-bearing U87 cells via CD4. All of the analogs inhibited T cell line-tropic strain HXB-2 (X4) and dual-tropic strain 89.6 (R5X4) HIV infections mediated by CXCR4, but had no effect on macrophage-tropic strain ADA (R5) or 89.6 HIV infections mediated by CCR5. The inhibition by T134 (IC50 of 2.70 nM) and T140 (IC50 of 0.432 nM) was also stronger than that by T22 (IC50 of 5.05 nM). The binding of anti-CXCR4 monoclonal antibody 12G5 to lymphoma-derived T cell line Sup-T1 was more efficiently blocked by T134 and T140 than by T22. Taken together, T22 and its analogs T134 and T140 exerted their inhibition by specific binding to CXCR4. The marked increase in the anti-HIV activity of T134 and T140 was ascribed to an enhancement in their ability to bind to CXCR4.


Subject(s)
Anti-HIV Agents/pharmacology , Antimicrobial Cationic Peptides , DNA-Binding Proteins/metabolism , HIV-1/drug effects , Peptides, Cyclic/metabolism , Peptides/metabolism , Receptors, CXCR4/metabolism , Amino Acid Sequence , Antibodies, Monoclonal , Cell Line , Cytopathogenic Effect, Viral , DNA-Binding Proteins/chemical synthesis , DNA-Binding Proteins/pharmacology , Flow Cytometry , Genetic Vectors , HIV Infections/virology , HIV-1/genetics , HIV-1/pathogenicity , Humans , Luciferases/metabolism , Molecular Sequence Data , Peptides/chemical synthesis , Peptides/chemistry , Peptides/pharmacology , Peptides, Cyclic/chemical synthesis , Peptides, Cyclic/pharmacology , Viral Envelope Proteins/genetics
18.
Infect Immun ; 67(4): 1623-32, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10084995

ABSTRACT

CD14 has been implicated as a receptor of lipoteichoic acid (LTA) and other bacterial components as well as lipopolysaccharide (LPS). Since the structures of LTAs from various gram-positive bacteria are heterogeneous, we analyzed the effects of LTAs on the secretion of interleukin-8 (IL-8) by high- and low-CD14-expressing (CD14(high) and CD14(low)) human gingival fibroblasts (HGF). While Bacillus subtilis LTA had an IL-8-inducing effect on CD14(high) HGF which was considerably weaker than that of LPS, Streptococcus sanguis and Streptococcus mutans LTAs had practically no effect on the cells. B. subtilis LTA had only a weak effect on CD14(low) HGF, as did LPS. S. sanguis and S. mutans LTAs at a 1,000-fold excess each completely inhibited the IL-8-inducing activities of both LPS and a synthetic lipid A on CD14(high) HGF. The effect of LPS was also inhibited by the presence of an LPS antagonist, synthetic lipid A precursor IVA (LA-14-PP), with a 100-fold higher potency than S. sanguis and S. mutans LTAs and by anti-CD14 monoclonal antibody (MAb). S. sanguis and S. mutans LTAs, LA-14-PP, and anti-CD14 MAb had no significant effect on phorbol myristate acetate-stimulated IL-8 secretion by HGF. These LTAs also inhibited the IL-8-inducing activity of B. subtilis LTA on CD14(high) HGF, as did LA-14-PP and anti-CD14 MAb. The antagonistic and agonistic functions of LTAs were also observed with human monocytes. Binding of fluorolabeled LPS to human monocytes was inhibited by S. sanguis LTA, although the inhibition was 100 times weaker than that of LPS itself, and anti-CD14 MAb inhibited fluorolabeled LPS and S. sanguis LTA binding. Binding of LTAs to CD14 was also observed with nondenaturing polyacrylamide gel electrophoresis. These results indicate that LTAs act as antagonists or agonists via a CD14-dependent mechanism, probably due to the heterogeneous structure of LTAs, and that an antagonistic LTA might be a useful agent for suppressing the periodontal disease caused by gram-negative bacteria.


Subject(s)
Lipopolysaccharide Receptors/metabolism , Lipopolysaccharides/agonists , Lipopolysaccharides/antagonists & inhibitors , Lipopolysaccharides/pharmacology , Teichoic Acids/pharmacology , Antibodies, Monoclonal/immunology , Bacillus subtilis , Fibroblasts/drug effects , Fibroblasts/metabolism , Gingiva/cytology , Humans , Interleukin-1 , Interleukin-8/metabolism , Lipid A/antagonists & inhibitors , Lipopolysaccharide Receptors/immunology , Monocytes/drug effects , Monocytes/metabolism , Streptococcus mutans , Streptococcus sanguis
19.
J Virol ; 73(2): 1719-23, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9882387

ABSTRACT

T22, an analog of polyphemusin II (18 amino acid residues), was found to block T-tropic human immunodeficiency virus type 1 (HIV-1) entry into target cells as a CXCR4 inhibitor. We synthesized T134, a small analog (14 amino acid residues) of T22 with reduced positive charges. T134 exhibited highly potent activity and significantly less cytotoxicity in comparison to that of T22. T134 prevents the anti-CXCR4 monoclonal antibody from binding to peripheral blood mononuclear cells but has no effect on the binding of anti-CCR5 monoclonal antibodies. Since T134 inhibits the binding of stromal cell-derived factor-1 (SDF-1) to MT-4 cells, it seems that T134 prevents HIV-1 entry by binding to CXCR4. The bicyclam AMD3100 has also been shown to block HIV-1 entry via CXCR4 but not via CCR5. Both T134 and AMD3100 are CXCR4 antagonists and low-molecular-weight compounds but have different structures. Our results indicate that T134 is active against wild-type T-tropic HIV-1 strains and against AMD3100-resistant strains.


Subject(s)
Anti-HIV Agents/pharmacology , HIV-1/drug effects , Heterocyclic Compounds/pharmacology , Peptides, Cyclic/pharmacology , Receptors, CXCR4/antagonists & inhibitors , Anti-HIV Agents/metabolism , Benzylamines , Cell Line, Transformed , Cyclams , Drug Resistance, Multiple , Heterocyclic Compounds/metabolism , Humans , Peptides, Cyclic/metabolism , Receptors, CXCR4/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...